Chemo Lecture 6: Targeted Therapy and biologicals Flashcards

1
Q

MOA and therapeutic use of imatinib

A
  • Imatinib occupies the ATP cofactor binding sites on Bcr, Abl fusion gene of CML, inhibiting transfer of phosphate to tyrosine on substrates.
  • GIST ( imatinib inhibits c-kit and PDGFR)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Therapeutic use of Dasatinib

A
  • primary and imatinib resistant CML (inhibits bcr-abl)

- GIST (dasatinib inhibits Src family)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mechanism of imatinib resistance

A
  • mutation of ATP binding pocket to exlcude imatinib

- Dasatinib can overcome imatinib resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Main adverse effects of imatinib

A

many drug interactions due to hepatic CYP450. Agents that induce CYP450 (e.g. st johns wort, rifampin) hasten clearance of imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List drugs that are membrane associated receptor tyrosine kinase inhibitors

A
  • Gefitnib
  • Erlotinib
  • Lapatinib
  • Sunitinib
  • Sorafenib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Erlotinib and gefitinib target which receptor and thus is useful for what cancer?

A

Blocks EGFR, useful for NSCLC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lapatinib blocks what receptors and thus is useful for what cancer?

A

EGFR and HER2, useful for breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sunitinib blocks what receptors and thus are useful for what cancers

A

Blocks C-kit, PDGFR, VEGFR, useful for GIST and RCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sorafenib blocks what receptor and thus used for what cancer?

A

blocks PDGFR and VEGFR, useful for RCC and HCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What drug blocks mutated form of BRAF kinase (V600E), and used for what cancer?

A

Vemurafenib, used for melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which antibodies target EGFR

A

Cetuximab and panitumumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which antibody target HER2

A

Transtuzumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which antibody targets VEGF?

A

Bevacizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is cetuximab used for?

A

Colorectal; head and neck cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is panitumumab used for?

A

Colorectal cancer (w/o KRAS mutation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is trastuzumab used for?

A

HER2+ breast cancer

17
Q

What is bevacizumab used for?

A

RCC

18
Q

Why is mutational status of KRAS a determinant of response to antibodies that inhibit EGFR activation?

A

Mutational activation of Ras can by-pass the upstream effect on EGFR tyrosine kinase

19
Q

what drugs are used as angiogenesis inhibitors?

A
  • Bevacizumab (antibody): targets VEGF and stop angiogenesis and tumor progression
  • Sunitinib and sorafenib (RTK inhibitors)
20
Q

Side effect of Bevacizumab

A
  • Severe high BP
  • Bleeding
  • Heart attack or HF
  • damage to body parts
21
Q

Why does RCC respond well to angiogenesis inhibitors?

A

RCC with VHL mutation governs degradation and clearance of hypoxia inducible factor (HIFa) transcription factory family which allows HIF proteins to accumulate and activate VEGF and PDGF. Angiogenesis inhibitors blocks VEGF

22
Q

antibody drug used to treat B cell lymphoma

A

Rituxomab (anti-CD20).

23
Q

MOA of rituxomab

A
  1. recruits complemnt proteins
  2. recruits NK cells, T cells, macrophages
  3. Binding of antibody signals apoptosis